{
    "company_name": "CLARITY PHARMACEUTICALS LTD",
    "address": "'National Innovation Centre', Suite 212a 2-4 Cornwallis Street, EVELEIGH, NSW, AUSTRALIA, 2015",
    "summary": "Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.",
    "details": "Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.",
    "website": "https://www.claritypharmaceuticals.com/",
    "stock_code": "CU6",
    "links": "['#content', 'https://www.claritypharmaceuticals.com/', 'https://www.claritypharmaceuticals.com/', '/about-us/', 'https://www.claritypharmaceuticals.com/about-us/', 'https://www.claritypharmaceuticals.com/about-us/management/', 'https://www.claritypharmaceuticals.com/about-us/board/', 'https://www.claritypharmaceuticals.com/about-us/scientific-advisors/', '/pipeline/', 'https://www.claritypharmaceuticals.com/pipeline/', 'https://www.claritypharmaceuticals.com/pipeline/sartate/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bispsma/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bbn/', 'https://www.claritypharmaceuticals.com/pipeline/scientific_presentations/', 'https://www.claritypharmaceuticals.com/technology/', 'https://www.claritypharmaceuticals.com/technology/', 'https://www.claritypharmaceuticals.com/technology/copper-isotopes/', 'https://www.claritypharmaceuticals.com/technology/ip/', 'https://www.claritypharmaceuticals.com/news/', 'https://www.claritypharmaceuticals.com/investor-center/', 'https://www.claritypharmaceuticals.com/investor-center/', 'https://www.claritypharmaceuticals.com/investor-center/reports_presentations/', 'https://www.claritypharmaceuticals.com/investor-center/science_hat/', 'https://www.claritypharmaceuticals.com/investor-center/videos/', 'https://www.linkedin.com/company/clarity-pharmaceuticals/', 'https://twitter.com/Clarity_Pharma', 'https://www.claritypharmaceuticals.com/', '/about-us/', 'https://www.claritypharmaceuticals.com/about-us/', 'https://www.claritypharmaceuticals.com/about-us/management/', 'https://www.claritypharmaceuticals.com/about-us/board/', 'https://www.claritypharmaceuticals.com/about-us/scientific-advisors/', '/pipeline/', 'https://www.claritypharmaceuticals.com/pipeline/', 'https://www.claritypharmaceuticals.com/pipeline/sartate/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bispsma/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bbn/', 'https://www.claritypharmaceuticals.com/pipeline/scientific_presentations/', 'https://www.claritypharmaceuticals.com/technology/', 'https://www.claritypharmaceuticals.com/technology/', 'https://www.claritypharmaceuticals.com/technology/copper-isotopes/', 'https://www.claritypharmaceuticals.com/technology/ip/', 'https://www.claritypharmaceuticals.com/news/', 'https://www.claritypharmaceuticals.com/investor-center/', 'https://www.claritypharmaceuticals.com/investor-center/', 'https://www.claritypharmaceuticals.com/investor-center/reports_presentations/', 'https://www.claritypharmaceuticals.com/investor-center/science_hat/', 'https://www.claritypharmaceuticals.com/investor-center/videos/', 'https://www.linkedin.com/company/clarity-pharmaceuticals/', 'https://twitter.com/Clarity_Pharma', 'https://www.claritypharmaceuticals.com/about-us/', '/technology/', 'https://www.claritypharmaceuticals.com/pipeline/sartate/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bispsma/', 'https://www.claritypharmaceuticals.com/pipeline/SAR-BBN/', 'https://www.claritypharmaceuticals.com/technology/', 'http://localhost:8888/news/', 'https://www.claritypharmaceuticals.com/news/northstar_clinial_supply/', 'https://www.claritypharmaceuticals.com/news/reatail_entitlement_booklet/', 'https://www.claritypharmaceuticals.com/news/placement_institutional_entitlement_offer/', 'https://www.claritypharmaceuticals.com/news/capital_raise-2024/', 'https://www.claritypharmaceuticals.com/news/secure_c4_fp/', 'https://www.claritypharmaceuticals.com/about-us/', 'https://www.claritypharmaceuticals.com/about-us/', 'https://www.claritypharmaceuticals.com/about-us/management/', 'https://www.claritypharmaceuticals.com/about-us/board/', 'https://www.claritypharmaceuticals.com/about-us/scientific-advisors/', 'https://www.claritypharmaceuticals.com/pipeline/', 'https://www.claritypharmaceuticals.com/pipeline/sartate/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bispsma/', 'https://www.claritypharmaceuticals.com/pipeline/sar-bbn/', 'https://www.claritypharmaceuticals.com/news/', 'https://www.claritypharmaceuticals.com/technology/', 'https://www.claritypharmaceuticals.com/pipeline/sartate/', 'https://www.claritypharmaceuticals.com/technology/copper-isotopes/', 'https://www.claritypharmaceuticals.com/technology/ip/', 'https://www.claritypharmaceuticals.com/investor-center/', 'mailto:bd@claritypharmaceuticals.com', 'https://www.linkedin.com/company/clarity-pharmaceuticals/', 'https://twitter.com/Clarity_Pharma', '#']",
    "images": "https://www.claritypharmaceuticals.com/wp-content/uploads/2020/03/clarity-pharmaceuticals-logo-2020.png, https://www.claritypharmaceuticals.com/wp-content/uploads/2020/03/clarity-pharmaceuticals-logo-2020.png, https://www.claritypharmaceuticals.com/wp-content/uploads/2021/10/Picture1.png, https://www.claritypharmaceuticals.com/wp-content/uploads/2021/08/clarity-reversed.png",
    "company_logo_link": "https://www.claritypharmaceuticals.com/wp-content/uploads/2020/03/clarity-pharmaceuticals-logo-2020.png"
}